Main variables	Main activity, secondary one or a tool necessary for production	Total
Companies that carry out R&D in Biotechnology	Total	1.079
Companies that carry out R&D in Biotechnology	Main	519
Companies that carry out R&D in Biotechnology	Secondary dwellings	179
Companies that carry out R&D in Biotechnology	Tool	381
%Companies according to biotechnology used: Genetic code	Total	35
%Companies according to biotechnology used: Genetic code	Main	46
%Companies according to biotechnology used: Genetic code	Secondary dwellings	29
%Companies according to biotechnology used: Genetic code	Tool	23
%Companies according to biotechnology used: Functional units	Total	44
%Companies according to biotechnology used: Functional units	Main	55
%Companies according to biotechnology used: Functional units	Secondary dwellings	40
%Companies according to biotechnology used: Functional units	Tool	32
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Total	26
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Main	34
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Secondary dwellings	24
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Tool	17
%Companies according to biotechnology used: Bioprocesses	Total	49
%Companies according to biotechnology used: Bioprocesses	Main	42
%Companies according to biotechnology used: Bioprocesses	Secondary dwellings	46
%Companies according to biotechnology used: Bioprocesses	Tool	61
%Companies according to biotechnology used: Sub-cellular organisms	Total	8
%Companies according to biotechnology used: Sub-cellular organisms	Main	12
%Companies according to biotechnology used: Sub-cellular organisms	Secondary dwellings	6
%Companies according to biotechnology used: Sub-cellular organisms	Tool	5
%Companies according to biotechnology used: Bio-computing	Total	23
%Companies according to biotechnology used: Bio-computing	Main	35
%Companies according to biotechnology used: Bio-computing	Secondary dwellings	15
%Companies according to biotechnology used: Bio-computing	Tool	10
%Companies according to biotechnology used: Nanobiotechnology	Total	15
%Companies according to biotechnology used: Nanobiotechnology	Main	23
%Companies according to biotechnology used: Nanobiotechnology	Secondary dwellings	13
%Companies according to biotechnology used: Nanobiotechnology	Tool	4
%Companies according to biotechnology used: Other	Total	12
%Companies according to biotechnology used: Other	Main	12
%Companies according to biotechnology used: Other	Secondary dwellings	18
%Companies according to biotechnology used: Other	Tool	10
%Company by field(s) of ultimate application of biotechnology use: Human Health	Total	48
%Company by field(s) of ultimate application of biotechnology use: Human Health	Main	68
%Company by field(s) of ultimate application of biotechnology use: Human Health	Secondary dwellings	43
%Company by field(s) of ultimate application of biotechnology use: Human Health	Tool	22
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Total	21
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Main	25
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Secondary dwellings	15
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Tool	17
%Company by field(s) of ultimate application of biotechnology use: Food products	Total	33
%Company by field(s) of ultimate application of biotechnology use: Food products	Main	25
%Company by field(s) of ultimate application of biotechnology use: Food products	Secondary dwellings	30
%Company by field(s) of ultimate application of biotechnology use: Food products	Tool	46
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Total	22
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Main	22
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Secondary dwellings	21
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Tool	22
%Company by field(s) of ultimate application of biotechnology use: Environment	Total	17
%Company by field(s) of ultimate application of biotechnology use: Environment	Main	15
%Company by field(s) of ultimate application of biotechnology use: Environment	Secondary dwellings	25
%Company by field(s) of ultimate application of biotechnology use: Environment	Tool	17
%Company by field(s) of ultimate application of biotechnology use: Industry	Total	15
%Company by field(s) of ultimate application of biotechnology use: Industry	Main	16
%Company by field(s) of ultimate application of biotechnology use: Industry	Secondary dwellings	20
%Company by field(s) of ultimate application of biotechnology use: Industry	Tool	10
Personnel in R&D in biotechnology (no. of persons)	Total	9.795
Personnel in R&D in biotechnology (no. of persons)	Main	5.614
Personnel in R&D in biotechnology (no. of persons)	Secondary dwellings	1.560
Personnel in R&D in biotechnology (no. of persons)	Tool	2.621
Personnel in R&D in biotechnology (no. of persons): Researchers	Total	5.573
Personnel in R&D in biotechnology (no. of persons): Researchers	Main	3.578
Personnel in R&D in biotechnology (no. of persons): Researchers	Secondary dwellings	874
Personnel in R&D in biotechnology (no. of persons): Researchers	Tool	1.122
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Total	4.222
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Main	2.036
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Secondary dwellings	686
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Tool	1.500
Personnel in R&D in biotechnology (no. of persons): women	Total	5.298
Personnel in R&D in biotechnology (no. of persons): women	Main	3.242
Personnel in R&D in biotechnology (no. of persons): women	Secondary dwellings	813
Personnel in R&D in biotechnology (no. of persons): women	Tool	1.243
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Total	2.925
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Main	1.944
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Secondary dwellings	462
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Tool	520
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Total	2.373
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Main	1.298
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Secondary dwellings	352
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Tool	724
Personnel in R&D in biotechnology (FTE)	Total	6.828,6
Personnel in R&D in biotechnology (FTE)	Main	4.507,9
Personnel in R&D in biotechnology (FTE)	Secondary dwellings	873,3
Personnel in R&D in biotechnology (FTE)	Tool	1.447,5
Personnel in R&D in biotechnology (FTE): Researchers	Total	4.106,5
Personnel in R&D in biotechnology (FTE): Researchers	Main	2.926,2
Personnel in R&D in biotechnology (FTE): Researchers	Secondary dwellings	542,5
Personnel in R&D in biotechnology (FTE): Researchers	Tool	637,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Total	2.722,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Main	1.581,7
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Secondary dwellings	330,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Tool	809,6
Personnel in R&D in biotechnology (FTE): women	Total	3.811,7
Personnel in R&D in biotechnology (FTE): women	Main	2.613,9
Personnel in R&D in biotechnology (FTE): women	Secondary dwellings	467,5
Personnel in R&D in biotechnology (FTE): women	Tool	730,3
Personnel in R&D in biotechnology (FTE): (women) Researchers	Total	2.190,7
Personnel in R&D in biotechnology (FTE): (women) Researchers	Main	1.587,2
Personnel in R&D in biotechnology (FTE): (women) Researchers	Secondary dwellings	290,9
Personnel in R&D in biotechnology (FTE): (women) Researchers	Tool	312,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Total	1.621
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Main	1.026,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Secondary dwellings	176,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Tool	417,6
Internal expenditure on R&D (thousands of euros)	Total	533.826
Internal expenditure on R&D (thousands of euros)	Main	364.396
Internal expenditure on R&D (thousands of euros)	Secondary dwellings	71.517
Internal expenditure on R&D (thousands of euros)	Tool	97.913
1) By nature of the expense: Current expenses	Total	492.955
1) By nature of the expense: Current expenses	Main	336.315
1) By nature of the expense: Current expenses	Secondary dwellings	63.751
1) By nature of the expense: Current expenses	Tool	92.889
1.1) Remuneration to researchers	Total	203.439
1.1) Remuneration to researchers	Main	146.489
1.1) Remuneration to researchers	Secondary dwellings	27.774
1.1) Remuneration to researchers	Tool	29.176
1.2) Remuneration to technicians and assistants	Total	96.850
1.2) Remuneration to technicians and assistants	Main	59.163
1.2) Remuneration to technicians and assistants	Secondary dwellings	11.408
1.2) Remuneration to technicians and assistants	Tool	26.279
1.3) Other current expenses	Total	192.666
1.3) Other current expenses	Main	130.663
1.3) Other current expenses	Secondary dwellings	24.568
1.3) Other current expenses	Tool	37.434
2) By nature of the expense: Capital expenses	Total	40.870
2) By nature of the expense: Capital expenses	Main	28.081
2) By nature of the expense: Capital expenses	Secondary dwellings	7.766
2) By nature of the expense: Capital expenses	Tool	5.024
2.1) Land and buildings	Total	7.521
2.1) Land and buildings	Main	3.628
2.1) Land and buildings	Secondary dwellings	3.306
2.1) Land and buildings	Tool	587
2.2) Equipment and instruments	Total	32.078
2.2) Equipment and instruments	Main	23.504
2.2) Equipment and instruments	Secondary dwellings	4.431
2.2) Equipment and instruments	Tool	4.144
2.3) Acquisition of specific R+D software	Total	1.270
2.3) Acquisition of specific R+D software	Main	949
2.3) Acquisition of specific R+D software	Secondary dwellings	28
2.3) Acquisition of specific R+D software	Tool	293
1) By origin of the funds: National funds	Total	432.869
1) By origin of the funds: National funds	Main	285.656
1) By origin of the funds: National funds	Secondary dwellings	66.748
1) By origin of the funds: National funds	Tool	80.466
1.1) Own funds	Total	319.046
1.1) Own funds	Main	209.128
1.1) Own funds	Secondary dwellings	49.733
1.1) Own funds	Tool	60.186
1.2) From companies	Total	39.253
1.2) From companies	Main	26.512
1.2) From companies	Secondary dwellings	5.269
1.2) From companies	Tool	7.473
1.3) Public Administration funds	Total	70.063
1.3) Public Administration funds	Main	47.559
1.3) Public Administration funds	Secondary dwellings	11.542
1.3) Public Administration funds	Tool	10.962
1.4) From Universities	Total	156
1.4) From Universities	Main	131
1.4) From Universities	Secondary dwellings	10
1.4) From Universities	Tool	14
1.5) From non profit private institutions	Total	4.351
1.5) From non profit private institutions	Main	2.326
1.5) From non profit private institutions	Secondary dwellings	194
1.5) From non profit private institutions	Tool	1.831
1) By origin of the funds: Foreign funds	Total	100.956
1) By origin of the funds: Foreign funds	Main	78.740
1) By origin of the funds: Foreign funds	Secondary dwellings	4.769
1) By origin of the funds: Foreign funds	Tool	17.447
2.1) From EU programmes	Total	20.070
2.1) From EU programmes	Main	15.152
2.1) From EU programmes	Secondary dwellings	3.718
2.1) From EU programmes	Tool	1.200
2.2) Other foreign funds	Total	80.886
2.2) Other foreign funds	Main	63.588
2.2) Other foreign funds	Secondary dwellings	1.051
2.2) Other foreign funds	Tool	16.247
Purchase of R&D services in biotechnology (thousands of euros)	Total	138.625
Purchase of R&D services in biotechnology (thousands of euros)	Main	109.756
Purchase of R&D services in biotechnology (thousands of euros)	Secondary dwellings	20.480
Purchase of R&D services in biotechnology (thousands of euros)	Tool	8.390
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Total	101.114
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Main	75.199
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Secondary dwellings	17.964
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Tool	7.950
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Total	37.512
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Main	34.557
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Secondary dwellings	2.515
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Tool	440
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Total	46
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Main	57
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Secondary dwellings	43
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Tool	33
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Total	13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Main	12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Secondary dwellings	15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Tool	14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Total	12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Main	14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Secondary dwellings	15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Tool	8
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Total	14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Main	14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Secondary dwellings	19
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Tool	12
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Total	19
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Main	21
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Secondary dwellings	23
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Tool	14
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Total	19
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Main	23
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Secondary dwellings	22
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Tool	13
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Total	18
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Main	19
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Secondary dwellings	16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Tool	16
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Total	37
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Main	41
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Secondary dwellings	42
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Tool	30
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Total	49
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Main	53
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Secondary dwellings	57
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Tool	41
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Total	19
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Main	21
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Secondary dwellings	20
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Tool	16
% Companies that have requested biotechnology patents	Total	15
% Companies that have requested biotechnology patents	Main	23
% Companies that have requested biotechnology patents	Secondary dwellings	13
% Companies that have requested biotechnology patents	Tool	6
Number of patents requested	Total	466
Number of patents requested	Main	349
Number of patents requested	Secondary dwellings	74
Number of patents requested	Tool	42
% Companies with income of an international origin related to biotechnological activities	Total	24,9
% Companies with income of an international origin related to biotechnological activities	Main	33
% Companies with income of an international origin related to biotechnological activities	Secondary dwellings	14,5
% Companies with income of an international origin related to biotechnological activities	Tool	18,8
% Turnover representing income of an international origin related to biotechnological activities	Total	0,9
% Turnover representing income of an international origin related to biotechnological activities	Main	11,2
% Turnover representing income of an international origin related to biotechnological activities	Secondary dwellings	0
% Turnover representing income of an international origin related to biotechnological activities	Tool	0,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Total	71,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Main	76,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Secondary dwellings	54,2
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Tool	32
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Total	28,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Main	23,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Secondary dwellings	45,8
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Tool	68
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Total	92,2
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Main	92,9
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Secondary dwellings	56,5
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Tool	92,4
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Total	2,4
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Main	2,2
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Secondary dwellings	23,8
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Tool	0,6
% Income of an international origin related with activities according to the classification: Operating source abroad	Total	1,3
% Income of an international origin related with activities according to the classification: Operating source abroad	Main	0,9
% Income of an international origin related with activities according to the classification: Operating source abroad	Secondary dwellings	19,7
% Income of an international origin related with activities according to the classification: Operating source abroad	Tool	0,7
% Income of an international origin related with activities according to the classification: Other	Total	4,2
% Income of an international origin related with activities according to the classification: Other	Main	4
% Income of an international origin related with activities according to the classification: Other	Secondary dwellings	.
% Income of an international origin related with activities according to the classification: Other	Tool	6,3